Physician profile
Robert J Friedman
NPI 1659465375
$3,282.14
in general payments reported to CMS, 2019-2025
18 companies · $715 in 2025
The $715 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $187 · 2021: $125 · 2022: $480 · 2023: $674 · 2024: $724 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,112.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,434.02 | 2021-2025 | |
| Pfizer INC. | $422.60 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $351.50 | 2020-2025 | Ajovy |
| Lundbeck LLC | $282.01 | 2022-2025 | Vyepti |
| Amgen INC. | $167.69 | 2019-2022 | |
| Bausch Health US, LLC | $142.63 | 2019 | |
| Allergan, INC. | $123.64 | 2019-2021 | |
| Lilly USA, LLC | $56.39 | 2020-2024 | Emgality |
| Upsher-Smith Laboratories LLC | $55.12 | 2019-2022 | |
| Eisai INC. | $49.57 | 2020 | |
| Neuronetics, INC. | $39.92 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.18 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $25.66 | 2021 | |
| Assertio Therapeutics, INC. | $25.17 | 2019 | |
| Alnylam Pharmaceuticals INC. | $21.35 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $20.50 | 2020 | |
| Sonex Health, INC. | $17.98 | 2023 | Sx-One Microknife |
| Impel Pharmaceuticals INC. | $13.21 | 2023 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.